SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary, next generation technologies for managing animal pest populations through fertility control, today announced the closing of its previously announced private placement of 4,388,854 shares of common stock (or common stock equivalents in lieu … [Read more...] about SenesTech, Inc. Announces Closing of $10 Million Private Placement Priced At-the-Market
Senestech
SenesTech to Present at the October 2020 Lytham Partners Virtual Investor Growth Conference
SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, is scheduled to participate in a virtual presentation and fireside chat at the October 2020 Lytham Partners Virtual Investor Growth Conference on Wednesday, October … [Read more...] about SenesTech to Present at the October 2020 Lytham Partners Virtual Investor Growth Conference
SenesTech Announces Pricing of $5.0 Million Public Offering Priced At-The-Market under Nasdaq Rules
SenesTech, Inc. (Nasdaq: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, today announced the pricing of its public offering of 1,574,308 units. Each unit is comprised of one share of common stock (or common stock equivalent) and one … [Read more...] about SenesTech Announces Pricing of $5.0 Million Public Offering Priced At-The-Market under Nasdaq Rules
Senestech Makes Key Hire for ContraPest
SenesTech, Inc., a developer of novel proprietary technologies for managing animal pest populations through fertility control, is hiring Dr. Sandra Alcaraz as vice president, regulatory affairs. The company also is providing further details on its international expansion strategy. Dr. Alcaraz is … [Read more...] about Senestech Makes Key Hire for ContraPest